Volitionrx (VNRX) Exchange Rate Effect (2011 - 2025)
Volitionrx (VNRX) posted Exchange Rate Effect of $264650.0 for Q4 2025, up 1126.65% on a QoQ basis from -$25778.0 in Q3 2025, and down 77.76% year-over-year from $1.2 million in Q4 2024.
Volitionrx (VNRX) Exchange Rate Effect (2011 - 2025) Analysis & Trends
Volitionrx's Exchange Rate Effect history runs 15 years deep, the most recent figure standing at $264650.0 for Q4 2025.
- Quarterly Exchange Rate Effect fell 77.76% year-over-year to $264650.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $532633.0 (up 54.54% YoY) and the FY2025 annual result came in at $532633.0, up 54.54% from the prior year.
- Exchange Rate Effect was $264650.0 for Q4 2025 at Volitionrx, up from -$25778.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.2 million in Q4 2024 and bottomed at -$663923.0 in Q3 2024.
- A 5-year average of $60321.4 and a median of $21717.5 in 2023 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 10026.27% in 2024, while the deepest fall reached 2195.52% in 2024.
- Volitionrx's Exchange Rate Effect stood at $120057.0 in 2021, then slumped by 177.08% to -$92544.0 in 2022, then surged by 112.7% to $11752.0 in 2023, then surged by 10026.27% to $1.2 million in 2024, then slumped by 77.76% to $264650.0 in 2025.
- Business Quant data shows VNRX's Exchange Rate Effect at $264650.0 in Q4 2025, -$25778.0 in Q3 2025, and $325102.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -23.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -19.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 33.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 8.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -2.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.66 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -37.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - | 264,650.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 264,650.00 |
| Dec 31, 2025 | 264,650.00 |
| Sep 30, 2025 | -25,778.00 |
| Sep 30, 2025 | -25,778.00 |
| Jun 30, 2025 | 325,102.00 |
| Jun 30, 2025 | 325,102.00 |
| Mar 31, 2025 | -31,341.00 |
| Mar 31, 2025 | -31,341.00 |
| Dec 31, 2024 | 1.19 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | -663,923.00 |
| Sep 30, 2024 | -663,923.00 |
| Jun 30, 2024 | 145,781.00 |
| Jun 30, 2024 | 145,781.00 |
| Mar 31, 2024 | -327,229.00 |
| Mar 31, 2024 | -327,229.00 |
| Dec 31, 2023 | 11,752.00 |
| Dec 31, 2023 | 11,752.00 |
| Sep 30, 2023 | 31,683.00 |
| Sep 30, 2023 | 31,683.00 |